Background J Kuruc 1, A Mayo 1,L Sampson 2, J Barnhart 2,M Brinson 5,S McCoy 3,E Foust 2, R Ashby 2, C Pilcher 4, C Gay 1,P Leone 1,2 and J Eron 1 1 University.

Slides:



Advertisements
Similar presentations
STAT Steve Beagle UNC CHAVI Field Coordinator
Advertisements

Nick Curry, MD, MPH Infectious Diseases Prevention Section
Combined Rapid and HIV RNA Testing in a Public STD Clinic: San Francisco, Jeffrey D. Klausner, Susan Philip, Katherine Ahrens, Giuliano Nieri,
Diagnosis and Management of Acute HIV Infection HIV Clinical Guidelines from the New York State Department of Health AIDS Institute January 2010 HIV CLINICAL.
Perspectives on Outreach from the NYC Department of Health and Mental Hygiene Benjamin Tsoi, MD, MPH Bureau of HIV/AIDS Prevention and Control NYC Department.
Risk Factors for Early Syphilis Among Men Who Have Sex With Men Seen in an STD Clinic – San Francisco, STD Prevention Conference: March 10, 2004.
Increased routine screening for syphilis and falling syphilis incidence in HIV positive and HIV negative men who have sex with men: implications for syphilis.
Impact of Age and Race on New HIV Infections among Men who have Sex with Men in Los Angeles County Shoshanna Nakelsky, MPH Division of HIV and.
Version 11Page 1 of 6 Improving Identification of Patients Infected with HIV Using Rapid Testing in the Emergency Department: A Systems-Based Approach.
Implementing screening for acute HIV infection in STD clinics already using rapid HIV antibody testing, New York City, 2007 Kathleen D. Gallagher, MPH.
STD Screening in HIV Clinics: Value and Implications Thomas Farley, MD MPH Tulane University Deborah Cohen, MD MPH RAND Corporation.
HIV Testing in Health-Care Settings
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
12/6/07 v.3CDC 2007 HIV Diagnostic Conference1 Diagnosis of HIV-1 Infection in Phase I & II HIV Vaccine Trials RW Coombs 1, J Dragavon 1, B Metch 2, CJ.
CDC HIV Diagnostics Conference December 5-7, 2007 Sensitivity of OraQuick and Early Generation Enzyme Immunoassay (EIA) within a Pooled HIV Nucleic Acid.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
Wisconsin HIV/AIDS Surveillance Annual Review: Slide Set New diagnoses, prevalent cases, and deaths through December 2014 April 2015 P Wisconsin.
Primary HIV Infection: the CDC study Pragna Patel, MD MPH Medical Epidemiologist Behavioral and Clinical Surveillance Branch DHAP, CDC February 28, 2005.
Recent Trends in Gonorrhea in the United States Lori M. Newman, MD Division of STD Prevention CDC Jacksonville, FL May 9, 2006.
Acute HIV in North Carolina STD Clinics The North Carolina STAT Project Peter A. Leone, MD Associate Professor of Medicine University of North Carolina.
Characteristics of clients undergoing repeat HIV counseling and testing compared to clients newly-tested for HIV in Nyanza Province Oyaro P, Owuor K, Ng’eno.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
Alternatives for acute HIV testing: RNA, p24, heat dissociated p24 Christopher D. Pilcher, MD University of North Carolina at Chapel Hill Center for AIDS.
STD Services in Detention in Los Angeles County Melina R. Boudov, MA Project Director LA County Infertility Prevention Project
Community HIV testing for men who have sex with men (MSM) Will it decrease undiagnosed infection? Jonathan Roberts Liaison Health Adviser Brighton & Sussex.
HIV Testing in Health- Care Settings Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings U.S. Centers.
Module 1: Final Case Study #1-CS-1. Case Study: Instructions v Try this case study individually. v We’ll discuss the answers in class. # 1-CS-2.
Changes in Sex Networks and Repeat STDs among Male Adolescents and Young Adults Jonathan M Ellen 1, Charlotte Gaydos 1, Michelle Chung 1, Nancy Willard.
Preventing HIV/AIDS There is no way to tell just by looking whether a person is infected with HIV. Because people are unaware that they are HIV-positive,
Evaluation of Gonorrhea Screening in Family Planning Settings: California 2000 CK Kent, M Brammeier, G Bolan, N Casas, M Funabiku, P Blackburn Region IX.
Trends in Herpes Simples Virus Type 2 infection in the United States — Data from NHANES Centers for Disease Control and Prevention (CDC) Emory University.
® Introduction Mental Health Predictors of Pain and Function in Patients with Chronic Low Back Pain Olivia D. Lara, K. Ashok Kumar MD FRCS Sandra Burge,
Bernard M. Branson, M.D. Associate Director for Laboratory Diagnostics Divisions of HIV/AIDS Prevention National Center for HIV/AIDS, Viral Hepatitis,
Universal HIV Testing Closing the Gap Peter A. Leone, MD Associate Professor of Medicine University of North Carolina Medical Director, NC HIV/STD Prevention.
San Francisco Department of Public Health HIV Partner Services Update 2011 San Francisco STD Prevention and Control Services May 2011.
Racial Disparities in Antiretroviral Therapy Use and Viral Suppression among Sexually Active HIV-infected Men who have Sex with Men— United States, Medical.
THE BODY PRO The HIV Resource for Health Care Professionals Copyright © 2009 The HealthCentral Network, Inc. All rights reserved. This activity is jointly.
Acute HIV JoAnn Kuruc, MSN, RN University of North Carolina.
Phylogenetic Insight into HIV Transmission Networks in a Southeastern US Cohort Ann Dennis 1, Stéphane Hué 2, Christopher Hurt 1, Sonia Napravnik 1, Deenan.
RTI International is a trade name of Research Triangle Institute Untreated chlamydial infection among adolescents and young adults in Baltimore,
ABSTRACT Introduction: HIV infection is growing relatively fast among seniors. Among the clinical implications are that older patients have less ability.
Faiza Ali MD, Ericka Hayes MD, Gaurav Kaushik MPH, Nicole Carr RN, Katie Plax MD Washington University School Of Medicine Department of Pediatrics.
November 2012 Prepared for the Contra Costa Board of Supervisors by Contra Costa Health Department Needle Exchange Update.
Acute HIV Follow-Up in NC Presented by Muhammad “Maxi” Mackalo, DIS.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System HIV in the United Kingdom: 2012 Overview.
Washington D.C., USA, July 2012www.aids2012.org Equal behaviors, unequal risks: The role of partner transmission potential in racial HIV disparities.
Florida Department of Health HIV/AIDS and Hepatitis Section Division of Disease Control and Health Protection Annual data trends as of 12/31/2012 Living.
1 Counseling and HIV Testing HAIVN Harvard Medical School AIDS Initiatives in Vietnam.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System RITA as part of routine national HIV surveillance: Experience.
Sexually Transmitted Disease (STD) Surveillance Report, 2013 Minnesota Department of Health STD Surveillance System Minnesota Department of Health STD.
The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and.
Florida Department of Health HIV/AIDS & Hepatitis Program Annual data trends as of 12/31/2012 Living (Prevalence) data as of 05/16/2012 Epidemiology of.
Sexually Transmitted Disease (STD) Surveillance Report, 2008 Minnesota Department of Health STD Surveillance System Minnesota Department of Health STD.
Preventing HIV/AIDS transmission on Historically Black Colleges and Universities (HBCUs) Peter Thomas, PhD, MPH Division of HIV/AIDS Prevention, Division.
Streamlined HIV Screening in a Municipal STI Clinic Kees Rietmeijer, MD, PhD Denver Public Health Department 2006 National STD Prevention Conference Jacksonville,
HIV Testing in Acute Care Settings Rich Rothman, MD, PhD, FACEP CDC, DHHS, OraSure Technologies, Abbott  Historical.
HIV and STI Department The case for HIV testing A presentation for the clinical team in your practice.
Inequalities in Sexual Health. Update on HIV and STIs in men who have sex with men in London Field Epidemiology Services PHE Publications gateway number:
HIV in America What’s New in 2012 Christopher Hurt, MD Clinical Assistant Professor NC AIDS Education and Training Center 2012 HIV Update.
Universal Opt-Out Screening for HIV in Health Care Settings, Cost Effectiveness in Action Douglas K. Owens, MD, MS VA Palo Alto Health Care System and.
NAAT identified chlamydial infections: Enhanced sensitivity, reduced transmissibility? Presenter: Maria Villarroel, MA Authors: Maria A. Villarroel, MA.
Herpes Simplex Virus Type 2 infection among U.S. military service members: Public Health Implications and Opportunities for HIV Prevention Christian T.
Katarina Grande, HIV Surveillance Coordinator Casey Schumann, HIV Epidemiologist Wisconsin Department of Health Services Statewide Action Planning Group.
Provider Initiated HIV Counseling and Testing Unit 2: Introduction and Rational for PIHCT.
Notified AIDS and HIV Infection Cases in the Seychelles: Epidemiological Trends Ministry of Health, SeychellesMinistry of Health, Seychelles –N. E. Udonwa.
CONCLUSIONS New Jersey’s Emergency Department HIV testing sites report higher seroprevalence than non-ED testing sites. Since University Hospital began.
Needle Exchange Update
STAT Steve Beagle UNC CHAVI Field Coordinator
Sexually Transmitted Infections (STIs) in Ireland, 2016
MSM Attending STD Clinics HIV Testing More Frequently: Implications for HIV Prevention and Surveillance D Helms1, H Weinstock1, K Mahle1, A Shahkolahi1,2,
Presentation transcript:

Background J Kuruc 1, A Mayo 1,L Sampson 2, J Barnhart 2,M Brinson 5,S McCoy 3,E Foust 2, R Ashby 2, C Pilcher 4, C Gay 1,P Leone 1,2 and J Eron 1 1 University of North Carolina at Chapel Hill, 2 North Carolina Department of Health and Human Services, 3 RTI International, 4 University of California, San Francisco, 5 North Carolina State Laboratory of Public Health Methods AbstractResults Conclusion XVIII International AIDS Conference 2009 Evaluation of Six Years of Statewide Screening and Testing for Acute HIV Infection in North Carolina References Figure 1. Description of the HIV testing procedures for detection of acute HIV in North Carolina. [1] 1.Pilcher CD, Fiscus SA, Nguyen TQ, Foust E, Wolf L, Williams D, et al. Detection of acute infections during HIV testing in North Carolina. N Engl J Med 2005,352: Patterson KB, Leone PA, Fiscus SA, Kuruc J, McCoy SI, Wolf, L et al. Frequent Detection of Acute HIV in Pregnant Women. AIDS, 2007; 21 (17): Hightow LB, Leone PA, MacDonald PD, et al. Men Who Have Sex With Men and Women: A Unique Risk Group for HIV Transmission on North Carolina College Campuses. STDs 2006;99: MOPEB006 The North Carolina (NC) Screening and Tracing Active Transmission (STAT) Program is a unique statewide collaboration to detect acute HIV infection (AHI) in publically funded testing sites. North Carolina Department of Health and Human Services (NC DHHS) introduced HIV-1 RNA pooling into the routine HIV testing algorithm in November EIA testing and pooling assays have changed during this 6 year period; the most dramatic being a change from a 2nd to a 3rd generation EIA. All clients presenting for VCT at approximately 135 publicly funded testing sites in NC are included in a testing algorithm to detect HIV-1 RNA positive, antibody negative acute HIV. [1] Samples with HIV-1 RNA detected and either EIA negative or EIA positive/Western Blot indeterminate are considered to represent unconfirmed acute infections. Potential AHI cases are assigned to a team of trained disease-intervention specialists (DIS) located throughout the state. DIS perform the initial interviews with AHI patients, confirmatory testing, and referrals to care within 72 hours of notification. DIS also perform partner notification and testing services prioritized by the date of exposure. EIA and HIV RNA tests used over the course of the program are depicted in Figure 2. In January of 2008, 3 rd generation EIA tests (BioRad) replaced 2 nd generation tests (bioMérieux). From January 1, 2003 to December 31, 2008, we identified 125 and 3,766 clients with acute and chronic HIV infections, respectively. NAAT testing increased case identification by 3.2% over standard antibody testing alone. Acutes were younger (p<0.0001), more likely to be men (p=0.05) more likely to be white (p=0.01) and more likely to be MSM (p<0.0001) compared to chronics. (Table 1) The proportion of the VCT and chronic HIV population with these characteristics remained relatively stable over time, while the composition of the AHI population was more dynamic (Figure 3a-d) HIV Prevalence in the VCT population declined from in both acute ( p=0.06) and chronic (p=0.002) groups. (Table 2). This decline may be due to increased testing in low-risk populations. For example, family planning and prenatal/OB sites accounted for 33% of all tests in 2003, rising to 38% in Figure 2. Timeline of HIV ELISA and RNA Tests Background: Since 2002, North Carolina (NC) has identified acute HIV infections (AHI) using nucleic acid amplification testing (NAAT) through a statewide program. Methods: All HIV antibody negative serum samples from publicly-funded voluntary testing and counseling (VCT) sites are tested for HIV RNA using specimen pooling. We calculated AHI and chronic HIV prevalence by calendar year and used linear regression to test for trends over time. We compared characteristics of people with acute and chronic HIV infection using the chi-squared test. Results: Between 1/1/2003 and 12/31/2008, 125 clients with AHI and 3,766 with chronic HIV were identified from 891,210 tests for an overall prevalence of 0.014% and 0.42%, respectively. Prevalence in the VCT testing population declined from in AHI (p=0.06) and chronic cases (p=0.002), likely due to an increase in testing among low- risk groups. NAAT testing increased case identification by 3.2% over standard antibody testing alone. Switching to a 3rd generation EIA in 2008 increased the number of AHI with EIA(+) results at diagnosis (vs. EIA(-); p=0.001). Acute cases were younger (28% ≤21 years vs. 14%; p<0.0001), more likely to be men (79% vs. 70%, p=0.05), more likely to be men who have sex with men (MSM; 58% vs. 34%; p<0.0001) and white (27% vs. 18%, p=0.01) than chronically infected clients. Among the 28% of adolescent acutes ≤ 21 years of age, 51% (N=18) were identified from (vs , p=0.03). Most adolescents were MSM of color (74%), compared to only 23% of adult acutes (p< ). Among female AHI cases (N=26), the median age was 30 years (range 16-48), the majority were African-American (73%) and 3 were pregnant. HIV risk factors for women with AHI included self/partner incarceration (37%), crack use (33%) and sex work (22%). The sex partners of six women (22%) were found to have been previously diagnosed HIV cases. Women were more likely to have an STI within 8 weeks of their AHI diagnosis (50% vs. 23% of men, p=0.01). Conclusions: AHI and chronic HIV prevalence declined in the VCT population from ; further analysis is needed to look at the composition of the tested group and to examine how it changed over time. AHI screening improves HIV cases missed by standard serological tests. Adolescents, especially young MSM of color, were more likely diagnosed with AHI. Women were less commonly diagnosed during AHI, potentially due to decreased risk perception but further research is needed. Characterizing populations with AHI may provide insight into improving early detection of HIV infection. 28% of acutes (N=35) were adolescents of whom 51% (N=18) were identified from (versus , p=0.03). Adolescent acutes were predominately MSM of color (74%), compared to only 23% of adult acutes (p< ). Among female AHI cases (N=26), median age was 30 years (range 16-48), the majority were African-American (73%) and 3 were pregnant. In total, 3.2% of infections identified by the STAT Program for antibody-plus-RNA HIV testing were AHI, which would have been either not identified or not confirmed using standard antibody based testing procedures. The programs’ success at identifying new HIV infections has led to significant policy changes in the state, including universal reflex RNA testing for EIA-negative specimens and mandatory re-testing of pregnant women in the 3 rd trimester. (2) The yield of AHI cases varied by site type and type of antibody tests performed. Improved sensitivity of current EIAs has resulted in a decreased number of cases presenting as EIA (-) and HIV-1 RNA (+). Decreased proportion of infected individuals in NC testing population may be due to increased testing among low risk populations following the adoption of the CDC’s opt-out testing in Testing for AHI is especially important in high risk populations such as young MSM of color, for whom these infections would have been missed. The recent increase in AHI detection may be due to increased testing from targeted outreach programs (3): to increased AHI/HIV education; or to increased high risk behaviors such as internet partner meeting. Although nearly 2/3 of HIV testers were women, a smaller percentage of women are detected during AHI than men. Plausible explanations include lower perceived risk among clients and providers, and greater barriers to care and prevention services among high-risk women. This study is supported by the generous contributions of the following NIH funded programs: the UNC CFAR (1P30AI ) and the Clinical and Translational Research Center at The North Carolina Translational and Clinical Sciences Institute (NC TraCS) (UL – 1RR025747) from The UNC Clinical Translation Science Award. We greatly appreciate the support of all study staff members, HIV care providers, and particularly the individuals who participated in this study. Additionally the authors are grateful for the hard work and dedication of Steve Beagle and the DIS Officers of the NC DHHS Switching to the 3rd generation EIA in 2008 increased the number of AHI cases with EIA(+) results at diagnosis (p=.001) (Table 3) AHI VCT CHI AHI VCT CHI AHI VCT CHI VCT CHI AHI Figure 3a-d. Proportion of acute, chronic, and overall testing population who were (a) ≤21 years old (b) women (c) non-white and (d) men who have sex with men by calendar year AHI, Acute HIV Infection; CHI, Chronic HIV Infection; VCT, Voluntary Counseling and Testing Population, previous positives removed (a) (d)(c) (b) Risk factors for women with AHI included self/partner incarceration (37%), crack use (33%) and sex work (22%). Sex partners of six women (22%) were previously diagnosed with HIV. Women were more likely to have an STI within 8 weeks of AHI diagnosis (50% vs. 23% of men, p=0.01).